Day: September 19, 2024

DALLAS, Sept. 19, 2024 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX) (the “Company”), a leading private markets solutions provider, will host an Investor Day in New York today, beginning at 8:30 a.m. Eastern Time. During the event, P10’s management team and strategy leadership will provide an in-depth presentation of the Company’s strategic vision, investment strategies, growth levers, and financial outlook. The formal presentations will be followed by a Q&A session, with the webcast portion of the event concluding by approximately 12:30 p.m. Eastern Time. The live webcast and supporting materials will be available through the following link: 2024 Investor Day. A replay will be made available following the conclusion of the event on Company’s investor relations page at www.p10alts.com. About P10P10 is a leading multi-asset class...

                                                First Unfold AI®-Assisted Focal One procedures successfully performed at the UCLA School of Medicine FDA-cleared Unfold AI enables urologists to provide tailored, patient-specific Robotic HIFU ablation for prostate cancer patients EDAP and Avenda Health to present Unfold AI-Assisted Focal One simulated procedures at the 2024 Joint Meeting of the Focal Therapy Society & Society of Urologic Robotic Surgeons in Washington, DC September 19-21, 2024LYON, France, September 19, 2024 – EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, and Avenda Health (“Avenda”), a leading AI healthcare company, today announced a collaboration agreement for the purpose of offering personalized prostate cancer care, utilizing Avenda’s groundbreaking AI technology, Unfold...

The new version 5.0 of the AI model EDEN™ features a novel toxin antigen predictor, is trained on an expanded dataset and includes an advanced protein prediction feature The launch will expectedly improve Evaxion’s ability to fast and effectively discover AI-derived novel vaccines and is expected to further solidify the strong interest seen in AI-Immunology™ from potential partners New data demonstrating the improved performance of EDEN™ will be presented today at the European Conference on Computational Biology in Turku, FinlandCOPENHAGEN, Denmark, Sept. 19, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, launches an enhanced version of its clinically validated AI-Immunology™...

Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) — Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual Scientific Meeting of the Heart Failure Society of America (HFSA), taking place September 27-30 at the Georgia World Congress Center and Signia by Hilton Atlanta. The event will gather the world’s top heart failure experts. Key meeting highlights:Exclusive showcase of BVA at the HFSA ‘Devices in Heart Failure: From Mechanisms to Implementation’ session. Presentation of products and services in the main Exhibit Hall. Corporate Member Meeting with HFSA leadership.“We’re excited to showcase how our BVA technology provides precise, actionable data, enabling clinicians to personalize treatment for both inpatient and outpatient...

ALG-055009 dose groups met the primary endpoint with statistically significant reductions in liver fat at Week 12 as measured by MRI-PDFF Placebo-adjusted median relative reductions in liver fat were up to 46.2% with a clear dose response ALG-055009 was well-tolerated with no serious adverse events or dose reductions. Importantly, ALG-055009 dose groups had a similar incidence of gastrointestinal-related adverse events with less diarrhea compared to placebo Significant reductions in atherogenic lipids, including LDL-C, lipoprotein (a), and apolipoprotein B were observed Conference call scheduled for 8:30am ET/5:30am PT todaySOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class...

WALNUT, CA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, today announced that it plans to release its financial results for the fiscal year ended June 30, 2024, before the market opens on Thursday, September 26th. Armlogi’s management team will hold an earnings conference call at 1:30 P.M. Pacific Time (4:30 P.M. Eastern Time) on Thursday, September 26th to discuss the Company’s financial results and provide an overview of the Company’s operations. Armlogi’s management team will lead the conference call and answer investor questions. Investors may submit written questions by Monday, September 23rd via...

DULUTH, Ga., Sept. 19, 2024 (GLOBE NEWSWIRE) — Fox Factory Holding Corp. (Nasdaq: FOXF) announced it is fielding its first team to compete in the Rebelle Rally, the longest competitive off-road navigation rally in the United States and the first women’s endurance off-road rally in America. Kristen Matlock, professional driver and FOX-supported athlete, along with Ashleigh Ballas, one of Fox Factory’s test engineers, will debut in the 4×4 class, driving a Fox Factory-designed and developed King of the Hammers Edition Ford Bronco. The team’s 2023 King of the Hammers edition Ford Bronco boasts a custom suspension package, specifically designed by Fox Factory in collaboration with off-road enthusiasts to optimize comfort, articulation, and capability. This state-of-the-art vehicle serves as a testament to both Ford’s...

SEATTLE, Sept. 19, 2024 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that effective at 12:01 a.m., EDT, on September 19, 2024, the Company will effect a one-for-fifty (1 for 50) reverse stock split of its outstanding Class A common stock. The reverse stock split is primarily intended to bring the Company into compliance with the minimum average closing share price requirement for maintaining its listing on the Nasdaq Capital Market. The Company’s common stock will continue to trade under the symbol “BNZI”. Upon the effectiveness of the reverse stock split, every fifty shares of issued and outstanding common stock before the open of business on September 19,...

TORONTO, Sept. 19, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and AI markets, today announced it has entered into a collaboration with Mitsubishi Electric Corporation (“Mitsubishi Electric”) to co-develop integrated optical engine chipsets for 3.2T pluggable transceivers, a highly sought-after product for optical connectivity in the rapidly growing artificial intelligence networking market. POET and Mitsubishi Electric will jointly support product demonstrations with major customers. “Mitsubishi Electric is committed to ensuring we give our customers the technological advantage to maintain their positions as...